78 related articles for article (PubMed ID: 20622331)
21. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index.
Alexiev BA; Bassarova AV; Popovska SL; Popov AA; Christov CZ
Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249
[TBL] [Abstract][Full Text] [Related]
22. Extraction and immobilization of SA-α-2,6-Gal receptors on magnetic nanoparticles to study receptor stability and interaction with Sambucus nigra lectin.
Gregorio-Jauregui KM; Carrizalez-Alvarez SA; Rivera-Salinas JE; Saade H; Martinez JL; López RG; Segura EP; Ilyina A
Appl Biochem Biotechnol; 2014 Apr; 172(8):3721-35. PubMed ID: 24566927
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the carbohydrate-binding activity of the NeuAc(alpha-2,6)Gal/GalNAc-specific type 2 ribosome-inactivating protein from elderberry (Sambucus nigra) fruits.
Chen Y; Rouge P; Peumans WJ; van Damme EJ
Biochem J; 2002 Jun; 364(Pt 2):587-92. PubMed ID: 12023903
[TBL] [Abstract][Full Text] [Related]
24. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
[TBL] [Abstract][Full Text] [Related]
25. Lectin binding and steroid receptors in human breast carcinomas.
Walker RA; Hawkins RA; Miller WR
J Pathol; 1985 Oct; 147(2):103-6. PubMed ID: 3840841
[TBL] [Abstract][Full Text] [Related]
26. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
27. Sialylation of intracellular proteins of thyroid lesions.
Krzeslak A; Gaj Z; Pomorski L; Lipinska A
Oncol Rep; 2007 May; 17(5):1237-42. PubMed ID: 17390071
[TBL] [Abstract][Full Text] [Related]
28. [The characteristics of lectin distribution and level in breast dysplasias and cancers].
Borodaĭ NV
Tsitol Genet; 1998; 32(1):49-55. PubMed ID: 9695252
[TBL] [Abstract][Full Text] [Related]
29. Breast lesions in young females--a 20-year study for significance of early recognition.
Malik R; Bharadwaj VK
Indian J Pathol Microbiol; 2003 Oct; 46(4):559-62. PubMed ID: 15025342
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of carbohydrate binding properties of Sambucus nigra lectins and ribosome-inactivating proteins.
Shang C; Van Damme EJ
Glycoconj J; 2014 Jul; 31(5):345-54. PubMed ID: 24853865
[TBL] [Abstract][Full Text] [Related]
31. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
32. Expression of alpha 2,6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin-conjugated Sambucus nigra agglutinin.
Dall'Olio F; Trerè D
Eur J Histochem; 1993; 37(3):257-65. PubMed ID: 7693064
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of C-erbB-2 and hormone receptors' status in human benign and malignant breast lesions.
Goussia A; Agnantis NJ; Athanassiadou S; Stefanou D
Anticancer Res; 1995; 15(5B):2313-8. PubMed ID: 8572645
[TBL] [Abstract][Full Text] [Related]
34. TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions.
Sirotkovic-Skerlev M; Cacev T; Krizanac S; Kulić A; Pavelic K; Kapitanovic S
Exp Mol Pathol; 2007 Aug; 83(1):54-8. PubMed ID: 17234183
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of galectin-3 is associated with progression of human breast cancer.
Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
[TBL] [Abstract][Full Text] [Related]
36. [Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof].
Xu WG; Wang G; Liu Y; Zou YH; Song JN; Yang XQ; Wang WY
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):802-4. PubMed ID: 18756980
[TBL] [Abstract][Full Text] [Related]
37. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
[TBL] [Abstract][Full Text] [Related]
38. Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
Merseburger AS; Kramer MW; Hennenlotter J; Simon P; Knapp J; Hartmann JT; Stenzl A; Serth J; Kuczyk MA
Prostate; 2008 Jan; 68(1):72-7. PubMed ID: 18008332
[TBL] [Abstract][Full Text] [Related]
39. [Expression of T and Tn antigens in breast cancers].
Konska G; Favy D; Guillot J; Bernard-Gallon D; de Latour M; Fonck Y
C R Seances Soc Biol Fil; 1998; 192(4):733-47. PubMed ID: 9842474
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
